Monday, August 07, 2023 5:20:08 PM
Recent TTOO News
- T2 Biosystems to Host Business Update Call on October 10, 2024 • GlobeNewswire Inc. • 10/08/2024 08:05:00 PM
- T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform • GlobeNewswire Inc. • 10/08/2024 01:00:00 PM
- T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens • GlobeNewswire Inc. • 10/07/2024 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2024 01:00:32 PM
- T2 Biosystems Announces Preliminary Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 10/07/2024 01:00:00 PM
- T2 Biosystems Highlights New Article Published in The Lancet: Changing the Culture of Blood Culture • GlobeNewswire Inc. • 09/23/2024 01:00:00 PM
- T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union • GlobeNewswire Inc. • 09/20/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 12:59:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 01:16:29 PM
- T2 Biosystems Receives FDA Clearance to Market the T2Candida Panel for Pediatric Patients • GlobeNewswire Inc. • 09/16/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 01:10:01 PM
- T2 Biosystems Provides Updates on its New Product Development Pipeline Progress • GlobeNewswire Inc. • 09/09/2024 01:00:00 PM
- T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 08/27/2024 08:05:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/23/2024 08:31:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:49:41 PM
- T2 Biosystems to Attend Upcoming Investor Conferences • GlobeNewswire Inc. • 08/01/2024 08:05:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/30/2024 04:15:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/29/2024 09:00:32 PM
- T2 Biosystems Announces Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 07/29/2024 08:05:00 PM
- T2 Biosystems Announces Commercial Expansion Through Malaysia and Indonesia Distributor • GlobeNewswire Inc. • 07/29/2024 08:02:00 PM
- T2 Biosystems to Report Second Quarter 2024 Financial Results and Business Updates on July 29, 2024 • GlobeNewswire Inc. • 07/22/2024 08:05:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/19/2024 09:04:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2024 08:16:31 PM
- T2 Biosystems Announces Commercial Expansion Through Hong Kong and Macau Distributor • GlobeNewswire Inc. • 06/25/2024 01:00:00 PM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • Oct 15, 2024 8:21 AM
Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM
One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM
CBD Life Sciences, Inc. Announces Strategic MOU with U.S. Armed Forces for Groundbreaking Mushroom Supplement • CBDL • Oct 15, 2024 8:00 AM
HealthLynked Files Non-Provisional Patent for AI-Powered Healthcare Assistant, ARi • HLYK • Oct 15, 2024 8:00 AM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM